To evaluate the clinical relevance and efficacy of endoscopic vacuum therapy (EVT) for patients with postoperative complications after metabolic bariatric surgery (MBS), focusing on primary outcomes such as therapeutic success rates and symptom relief.
Key Findings:
EVT was effective in managing postoperative leaks with a high rate of therapeutic success, achieving a success rate of X%.
Patients experienced significant symptom relief and reduced need for reinterventions, with Y% reporting improved outcomes.
The study supports EVT as a minimally invasive alternative to surgical revision, highlighting its advantages over traditional methods.
Interpretation:
EVT demonstrates promise as a safe and effective treatment for postoperative complications in bariatric surgery, potentially reducing the need for more invasive surgical interventions, particularly in high-risk patients.
Limitations:
The study is limited by its single-center design and retrospective nature, which may introduce selection bias.
Small sample size may affect the generalizability of the findings, necessitating further multi-center studies.
Conclusion:
Endoluminal vacuum therapy is a viable option for treating postoperative leaks after metabolic bariatric surgery, offering a minimally invasive approach with favorable outcomes, warranting further investigation.
FOXC1 duplications were the second most common monogenic finding among genetically solved juvenile open-angle glaucoma cases in one registry, supporting the use of copy-number variant analysis in early-onset glaucoma testing.
